Search

Your search keyword '"Sachdeva, Karan"' showing total 110 results

Search Constraints

Start Over You searched for: Author "Sachdeva, Karan" Remove constraint Author: "Sachdeva, Karan"
110 results on '"Sachdeva, Karan"'

Search Results

3. Prevalence and Predictors of Barrett’s Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases

5. Rates of Recurrent Intestinal Metaplasia and Dysplasia After Successful Endoscopic Therapy of Barrett's Neoplasia by Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection and Ablation: A Large North American Multicenter Cohort.

6. Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study.

8. Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study

9. S1913 Quantification of Interstitial Cells of Cajal in the Gastric Muscles of Patients With or Without Gastroparesis

12. S1889 The Influence of Psychiatric Factors on Healthcare Resource Utilization in Patients with Gastroparesis: A National Population Based Study

13. S726 Presence of Esophagitis and Gastritis in Gastroparesis vs Non-Gastroparesis Patients

14. S1856 Comparing GERD Health-Related Quality of Life and Reflux Symptom Index Scores (RSI) in Patients With and Without Gastroparesis

15. S480 Efficacy and Safety of Z-POEM and D-POEM for Treatment of Esophageal Diverticula: A Single Center Experience

16. S1020 Evaluating Subclinical Atherosclerosis Using Vascular Parameters in Inflammatory Bowel Disease Patients: A Meta-Analysis

17. PREVALENCE AND PREDICTORS OF BARRETT’S ESOPHAGUS AFTER NEGATIVE INITIAL ENDOSCOPY: ANALYSIS FROM TWO NATIONAL DATABASES

18. RATES OF RECURRENT INTESTINAL METAPLASIA AND DYSPLASIA AFTER SUCCESSFUL ENDOSCOPIC THERAPY OF BARRETT'S NEOPLASIA BY CAP ASSISTED EMR VS ESD AND ABLATION: RESULTS FROM A LARGE NORTH AMERICAN MULICENTER COHORT

19. ALGORITHMIC APPROACH TO DIFFERENTIATE BETWEEN NON-SPECIFIC AND SPECIFIC ETIOLOGIES OF CHRONIC TERMINAL ILEITIS

20. PREVALENCE AND PREDICTORS OF BARRETT’S ESOPHAGUS AFTER A NEGATIVE INDEX ENDOSCOPY: A MULTICENTER HEALTH RECORD NETWORK STUDY

21. Revised Algorithmic Approach to Differentiate Between Nonspecific and Specific Etiologies of Chronic Terminal Ileitis

22. Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas

23. Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring

24. S1541 Algorithmic Approach to Differentiate Between Non-Specific and Specific Etiologies of Chronic Terminal Ileitis

26. S573 Efficacy of Rifaximin in Patients With Abdominal Bloating or Distension: A Systematic Review and Meta-Analysis

29. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial

30. RECURRENCE OF INTESTINAL METAPLASIA AND DYSPLASIA IN PATIENTS SUCCESSFULLY TREATED WITH RADIOFREQUENCY AND CRYO-BALLOON ABLATION: A PROPENSITY SCORE MATCHED COMPARATIVE ANALYSIS

32. 540: DEVELOPMENT OF A COMPUTATIONAL MACHINE LEARNING ESOPHAGEAL ADENOCARCINOMA AND BARRETT'S ESOPHAGUS RISK PREDICTION MODEL FROM A DEIDENTIFIED ELECTRONIC MEDICAL RECORD DATABASE

33. 691: DEVELOPMENT OF A DEEP LEARNING MODEL FOR WHOLE SLIDE IMAGE ANALYSIS IN THE HISTOLOGIC DIAGNOSIS OF DYSPLASTIC BARRETT'S ESOPHAGUS

35. 555a: COMBINATION OF FECAL MICROBIOTA TRANSPLANTATION AND ANTI-INFLAMMATORY DIET INDUCES CLINICAL AND DEEP REMISSION IN PATIENTS WITH MILD-MODERATE ULCERATIVE COLITIS

43. 224 EXTERNAL VALIDATION OF A DEEP LEARNING MODEL FOR WHOLE SLIDE IMAGE ANALYSIS IN THE HISTOLOGIC DIAGNOSIS OF DYSPLASTIC BARRETT'S ESOPHAGUS

Catalog

Books, media, physical & digital resources